Transaction Date | Recipient | Shares | Type | Price | Value |
---|---|---|---|---|---|
31st December 2020 | Richard C Jr Pfenniger | 3,125 | Grant/award etc. | $0.00 | |
31st December 2020 | Richard C Jr Pfenniger | 2,800 | Grant/award etc. | $0.00 | |
30th September 2020 | Richard C Jr Pfenniger | 2,198 | Grant/award etc. | $0.00 | |
30th September 2020 | David Bruce Milne | 14,750 | Grant/award etc. | $0.00 | |
30th September 2020 | Richard C Jr Pfenniger | 16,500 | Grant/award etc. | $0.00 | |
30th September 2020 | Richard C Jr Pfenniger | 3,125 | Grant/award etc. | $0.00 | |
3rd July 2020 | Anthony C. J. Fernando | 17,949 | Exercise of derivative | $0.00 | |
30th June 2020 | Brett Farabaugh | 30,000 | Exercise of derivative | $0.00 | |
30th June 2020 | Richard C Jr Pfenniger | 2,403 | Grant/award etc. | $0.00 | |
30th June 2020 | Richard C Jr Pfenniger | 3,125 | Grant/award etc. | $0.00 |
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 3/10.
TransEnterix, Inc. is a medical device company. It focuses on commercialization of Senhance System, that digitizes laparoscopic minimally invasive surgery. The company was founded by William N. Starling in 2006.
6th November 2020
6th November 2020
6th November 2020